Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign

被引:389
作者
Greene, Reginald E.
Schlamm, Haran T.
Oestmann, Joerg -W.
Stark, Paul
Durand, Christine
Lortholary, Olivier
Wingard, John R.
Herbrecht, Raoul
Ribaud, Patricia
Patterson, Thomas F.
Troke, Peter F.
Denning, David W.
Bennett, John E.
de Pauw, Ben E.
Rubin, Robert H.
机构
[1] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Pfizer Global Res & Dev, New York, NY USA
[4] Univ Calif San Diego, La Jolla, CA 92093 USA
[5] Univ Florida, Coll Med, Gainesville, FL 32611 USA
[6] Univ Texas, Hlth Sci Ctr, San Antonio, TX 78285 USA
[7] NIAID, Bethesda, MD 20892 USA
[8] Charite Univ Med Berlin, Berlin, Germany
[9] Hop Bocage, Dijon, France
[10] Inst Pasteur, Paris, France
[11] Hop St Louis, Paris, France
[12] Hop Hautepierre, Strasbourg, France
[13] Pfizer Global Res & Dev, Sandwich, Kent, England
[14] Univ Manchester, Manchester M13 9PL, Lancs, England
[15] Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
关键词
D O I
10.1086/509917
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Computed tomography ( CT) of the chest may be used to identify the halo sign, a macronodule surrounded by a perimeter of ground- glass opacity, which is an early sign of invasive pulmonary aspergillosis ( IPA). This study analyzed chest CT findings at presentation from a large series of patients with IPA, to assess the prevalence of these imaging findings and to evaluate the clinical utility of the halo sign for early identification of this potentially life- threatening infection. Methods. Baseline chest CT imaging findings from 235 patients with IPA who participated in a previously published study were systematically analyzed. To evaluate the clinical utility of the halo sign for the early identification and treatment of IPA, we compared response to treatment and survival after 12 weeks of treatment in 143 patients who presented with a halo sign and in 79 patients with other imaging findings. Results. At presentation, most patients ( 94%) had >= 1 macronodules, and many ( 61%) also had halo signs. Other imaging findings at presentation, including consolidations ( 30%), infarct- shaped nodules ( 27%), cavitary lesions ( 20%), and air- crescent signs ( 10%), were less common. Patients presenting with a halo sign had significantly better responses to treatment ( 52% vs. 29%;) and greater survival to 84 days ( 71% vs. 53%;) than P <= .001 P <= .01 did patients who presented with other imaging findings. Conclusions. Most patients presented with a halo sign and/ or a macronodule in this large imaging study of IPA. Initiation of antifungal treatment on the basis of the identification of a halo sign by chest CT is associated with a significantly better response to treatment and improved survival.
引用
收藏
页码:373 / 379
页数:8
相关论文
共 57 条
[31]   THE VALUE OF BRONCHOALVEOLAR LAVAGE AND BRONCHIAL WASHINGS IN THE DIAGNOSIS OF INVASIVE PULMONARY ASPERGILLOSIS [J].
LEVY, H ;
HORAK, DA ;
TEGTMEIER, BR ;
YOKOTA, SB ;
FORMAN, SJ .
RESPIRATORY MEDICINE, 1992, 86 (03) :243-248
[32]   INVASIVE ASPERGILLOSIS OF THE AIRWAYS - RADIOGRAPHIC, CT, AND PATHOLOGICAL FINDINGS [J].
LOGAN, PM ;
PRIMACK, SL ;
MILLER, RR ;
MULLER, NL .
RADIOLOGY, 1994, 193 (02) :383-388
[33]   Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation [J].
Maertens, J ;
Verhaegen, J ;
Lagrou, K ;
Van Eldere, J ;
Boogaerts, M .
BLOOD, 2001, 97 (06) :1604-1610
[34]   Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors [J].
Marr, KA ;
Carter, RA ;
Boeckh, M ;
Martin, P ;
Corey, L .
BLOOD, 2002, 100 (13) :4358-4366
[35]   THE MANAGEMENT OF PNEUMONIAS IN IMMUNOCOMPROMISED PATIENTS [J].
MASUR, H ;
SHELHAMER, J ;
PARRILLO, JE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (12) :1769-1773
[36]   SIGNIFICANCE OF ASPERGILLUS SPECIES ISOLATED FROM RESPIRATORY SECRETIONS IN THE DIAGNOSIS OF INVASIVE PULMONARY ASPERGILLOSIS [J].
NALESNIK, MA ;
MYEROWITZ, RL ;
JENKINS, R ;
LENKEY, J ;
HERBERT, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 1980, 11 (04) :370-376
[37]   Invasive pulmonary aspergillosis [J].
Oren, I ;
Goldstein, N .
CURRENT OPINION IN PULMONARY MEDICINE, 2002, 8 (03) :195-200
[38]  
ORR DP, 1978, CANCER-AM CANCER SOC, V41, P2028, DOI 10.1002/1097-0142(197805)41:5&lt
[39]  
2028::AID-CNCR2820410551&gt
[40]  
3.0.CO